article thumbnail

Lilly preps for rollout of its connected diabetes system

pharmaphorum

Taken together, the system can support patients with medication reminders, education resources, insulin dose logging and feedback on blood glucose levels, while a hub for physicians called Tempo Insights to help them make decisions about patient care based on data. The system works as follows.

article thumbnail

Roche and PatchAi partner on digital tool for cancer patients

pharmaphorum

Roche and PatchAi have been working together on the Smart Health Companion (SHC), which was launched to oncology and haematology patients in July 2020, and will now step up their collaboration to offer it more widely.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Pharmacists Can Manage Stress and Maximize Efficiency

Digital Pharmacist

This automated system can help minimize the amount of time your staff has to spend on the phone, enabling patients to refill and transfer prescriptions and get essential pharmacy information. Streamline patient communication on a secure platform that helps you send reminders, share images, and contact patients quickly and easily.

HIPAA 98
article thumbnail

Microsoft puts AI at heart of digital health strategy with Nuance deal

pharmaphorum

billion deal to buy Nuance Communications and its artificial intelligence platform for speech recognition that is increasingly being used for clinical applications. . Microsoft has made its aspirations in digital health clear with a whopping $19.7

article thumbnail

What HCPs think about COVID-19’s impact on cancer

pharmaphorum

COVID-19’s knock-on effect on cancer patients is of concern by HCPs, with delayed or decreased diagnosis seen as a key worry. The COVID-19 pandemic has been mainstream headline news throughout 2020 and continues to have a profound impact on all our lives. — Professor Karol Sikora (@ProfKarolSikora) April 22, 2020.

Hospitals 123
article thumbnail

FDA holds back from action over Xeljanz safety study

pharmaphorum

billion in the first nine months of 2020, up 10% overall and 23% in ex-US markets. We will communicate our final conclusions and recommendations when we have completed our review or have more information to share.”. First approved in 2o12, Xeljanz brought in sales of more than $1.7

FDA 58
article thumbnail

5 Things To Know About Antimicrobial Stewardship Regulatory Standards

IDStewardship

The most recent CARB addresses the years 2020-2025, building upon the initial one released in 2015. COVID-19 wasn’t the only thing to come to us in 2020. The same year, Joint Commission released medication management standards for antimicrobial stewardship in ambulatory health care.

Hospitals 236